[Home ] [Archive]    
:: Main About journal Editorial Board Current Issue Archive Submit an article Site Map Contact ::
Main Menu
Home::
Journal Information::
Articles archive::
For Authors::
For Reviewers::
Registration::
Contact us::
Site Facilities::
Editorial Board::
::
Search in website

Advanced Search
..
Receive site information
Enter your Email in the following box to receive the site news and information.
..
:: Volume 4, Issue 1 (march 2015) ::
Int J Med Invest 2015, 4(1): 152-160 Back to browse issues page
Hospital-Acquired Infections, Bacterial Causative Agents And Antibiotic Resistance Pattern In Intensive Care Units At Teaching Hospitals In North Of Iran
Farhang Babamahmoodi , Fatemeh Ahangarkani , Alireza Davoudi *
1- Antimicrobial Resistance Research Center, Department of Infectious Diseases, Mazandaran University of Medical Sciences, Sari, Iran
Abstract:   (13205 Views)
Abstract aim: HAIs (Hospital-Acquired Infections) remain a major problem in ICUs. The purpose of this study is survey of HAIs and antibiotic susceptibility patterns of causative agent among patients admitted in ICUs. Methods: A retrospective study was conducted in three teaching hospitals related to Mazandaran University of Medical Sciences in 2012-2014. The incidence, clinical presentation, risk factors, causative agents and antibiotic resistance pattern of bacteria analyzed by SPSS (ver. 16) and Descriptive statistics were used. Results: The incidences of HAIs were 4.13%. The most common HAIs were respiratory infection 49.1%, wound infection 26.3%, UTI 16.7%, and blood Infection 7.9%. P. aeruginosa 42.1%, Acinetobacter spp. 21.05%, Enterobacteriaceae 19.29% and S. aureus 12.28% were the most bacteria isolated. We found that 35% ESBL and 14.58% carbapenemase-producer Pseudomonas spp. Also 60% of Acinetobacter spp were MDR and 14.28% of S.aureus was resistant to niVnmocnaV. Conclusion: This article suggests that the prevalence of HAIs in ICUs of teaching hospitals in northern Iran is false low. Diagnosing of NI in our area focused on physician diagnosis and clinical criteria for reporting HAIs, The rate of inappropriate administration of antibiotics is very high in our region also significant resistance in organisms such as Acinetobacter spp, P. aeruginosa, Enterobacteriaceae, S. aureus to the most commonly used antibiotics has been increasing. Infection control procedures must be implemented carefully and Antibiotic resistance patterns of organisms causing HAIs should be checked periodically to guide empirical antibiotic therapy.
Keywords: Hospital-Acquired Infection, ICUs, Antibiotic resistance
Full-Text [PDF 467 kb]   (2778 Downloads)    
Type of Study: Research | Subject: General
References
1. 1. Girou E, Stephan F, Novara A, Safar M, Fagon JY. Risk factors and outcome of nosocomial infections: results of a matched case-control study of ICU patients. Am J Respir Crit Care Med. 1998;157(4 Pt 1):1151-8. 2. Kollef M. SMART approaches for reducing nosocomial infections in the ICU. Chest. 2008;134(2):447-56. 3. Healthcare-Associated Infection Working Group of the Joint Public Policy Committee, Essentials of Public Reporting of Healthcare- Associated Infections: A Tool Kit. Centers for Disease Control and Prevention Web site. http://www.cdc.gov/ncidod/dhqp/pdf/ar/ 06_107498_Essentials_Tool_Kit.pdf. Accessed Jan 16, 2009. 4. Lee TB, Montgomery OG, Marx J, Olmsted RN, Scheckler WE. Recommended practices for surveillance: Association for Professionals in Infection Control and Epidemiology (APIC), Inc. Am J Infect Control. 2007;35(7):427-40. 5. Masoumi A. directory of nosocomial infections surveillance system . Tehran. The center of management of contagious diseases: Ministry of Health and Medical Education of Islamic Republic of Iran. 2th edition. 2007. 6. Collee J, Miles R, Watt B. Tests for the identification of bacteria. 14th, editor. New York: Churchill Livingstone; 1996. 7. Koneman E, Allen S, Janda W, Schreckenberger R, Winn W. Introduction to microbiology. Part II: Guidelines for the collection transport, processing analysis and reporting of culture from specific specimen sources. 5th, editor. Philadelphia: Lippincott–Raven; 1997. 8. Clinical and Laboratory Standards Institute (CLSI) .Performance standards for antimicrobial susceptibility testing. Twent Informational Suppl. 2010;29:1-160. 9. Rosenthal VD, Maki DG, Salomao R, Moreno CA, Mehta Y, Higuera F, et al. Device-associated nosocomial infections in 55 intensive care units of 8 developing countries. Ann Intern Med. 2006;145(8):582-91. 10. Legras A, Malvy D, Quinioux AI, Villers D, Bouachour G, Robert R, et al. Nosocomial infections: prospective survey of incidence in five French intensive care units. Intensive Care Med. 1998;24(10):1040-6. 11. Dettenkofer M, Ebner W, Hans FJ, Forster D, Babikir R, Zentner J, et al. Nosocomial infections in a neurosurgery intensive care unit. Acta Neurochir (Wien). 1999;141(12):1303-8. 12. Gibbons C, Bruce J, Carpenter J, Wilson AP, Wilson J, Pearson A, et al. Identification of risk factors by systematic review and development of risk-adjusted models for surgical site infection. Health Technol Assess. 2011;15(30):1-156. 13. Zolldann D, Haefner H, Poetter C, Buzello S, Sohr D, Luetticken R, et al. Assessment of a selective surveillance method for detecting nosocomial infections in patients in the intensive care department. Am J Infect Control. 2003;31(5):261-5. 14. Sohrabi M, Khosravi A, Zolphaghari P, Sarraf J. Evaluation of frequency of nosocomial infections Shahrood Imam Hossein hospital. J Birjand Univ Med Sci. 2009;16(3):33-9. 15. Vardakas K, Siempos I, Falagas M. Diabetes mellitus as a risk factor for nosocomial pneumonia and associated mortality. Diabet Med. 2007;24(10):1168-71. 16. Yamashita S, Yamaguchi H, Sakaguchi M, Satsumae T, Yamamoto S, Shinya F. Longer-term diabetic patients have a more frequent incidence of nosocomial infections after elective gastrectomy. Anesth Analg. 2000;91(5):1176-81. 17. Rojas M, Efird M, Lozano J, Bose C, Rojas M, Rondón M, et al. Risk factors for nosocomial infections in selected neonatal intensive care units in Colombia, South America. J Perinatol. 2005;25(8):537-41. 18. Kamboj M, Sepkowitz KA. Nosocomial infections in patients with cancer. Lancet Oncol. 2009;10(6):589-97. 19. DiCocco JM, Croce MA. Ventilator-associated pneumonia: an overview. Expert Opin Pharmacother. 2009;10(9):1461-7. 20. Kampf G, Wischnewski N, Schulgen G, Schumacher M, Daschner F. Prevalence and risk factors for nosocomial lower respiratory tract infections in German hospitals. J Clin Epidemiol. 1998;51(6):495-502. 21. Richards MJ, Edwards JR, Culver DH, Gaynes RP. Nosocomial infections in medical intensive care units in the United States. National Nosocomial Infections Surveillance System. Crit Care Med. 1999;27(5):887-92. 22. Ding JG, Sun QF, Li KC, Zheng MH, Miao XH, Ni W, et al. Retrospective analysis of nosocomial infections in the intensive care unit of a tertiary hospital in China during 2003 and 2007. BMC Infect Dis. 2009;9:115. 23. Huang J, Chen EZ, Qu HP, Mao EQ, Zhu ZG, Ni YX, et al. Sources of multidrug-resistant Acinetobacter baumannii and its role in respiratory tract colonization and nosocomial pneumonia in intensive care unit patients. Chin Med J (Engl). 2013;126(10):1826-31. 24. Frankel H, Sperry J, Kaplan L. Risk factors for pressure ulcer development in a best practice surgical intensive care unit. Am Surg. 2007;73(12):1215-7. 25. Fife C, Otto G, Capsuto EG, Brandt K, Lyssy K, Murphy K, et al. Incidence of pressure ulcers in a neurologic intensive care unit. Crit Care Med. 2001;29(2):283-90. 26. Zahraei SM, Eshrati B, Masoumi Asl H, Pezeshki Z. Epidemiology of four main nosocomial infections in Iran during March 2007 - March 2008 based on the findings of a routine surveillance system. Arch Iran Med. 2012;15(12):764-6. 27. Saint S, Wiese J, Amory JK, Bernstein ML, Patel UD, Zemencuk JK, et al. Are physicians aware of which of their patients have indwelling urinary catheters? Am J Med. 2000;109(6):476-80. 28. Haley RW, Hooton TM, Culver DH, Stanley RC, Emori TG, Hardison CD, et al. Nosocomial infections in U.S. hospitals, 1975-1976: estimated frequency by selected characteristics of patients. Am J Med. 1981;70(4):947-59. 29. Saint S, Kowalski CP, Kaufman SR, Hofer TP, Kauffman CA, Olmsted RN, et al. Preventing hospital-acquired urinary tract infection in the United States: a national study. Clin Infect Dis. 2008;46(2):243-50. 30. Maki DG, Tambyah PA. Engineering out the risk for infection with urinary catheters. Emerg Infect Dis. 2001;7(2):342-7. 31. Sharifi M. Bacteriuria due to application of urinary catheter in the neurosurgery ward of Taleghani hospital of Kermanshah.Med J Tabriz Univ Med Sci. 2009;51(35):45-51. 32. Aminizadeh Z, Kashi M. Prevalence of multi-drug resistance and pandrug resistance among multiple gram-negative species: experience in one teaching hospital, Tehran, Iran. Int Res J Microbiol 2011;2:90-5. 33. Naidoo R, Nuttall J, Whitelaw A, Eley B. Epidemiology of Staphylococcus aureus Bacteraemia at a Tertiary Children's Hospital in Cape Town, South Africa. PLoS One. 2013;8(10):e78396. 34. Lee HG, Jang J, Choi JE, Chung DC, Han JW, Woo H, et al. Blood Stream Infections in Patients in the Burn Intensive Care Unit. Infect Chemother. 2013;45(2):194-201. 35. Kaasch AJ, Barlow G, Edgeworth JD, Fowler VG, Jr., Hellmich M, Hopkins S, et al. Staphylococcus aureus bloodstream infection: a pooled analysis of five prospective, observational studies. J Infect. 2013. 36. Mylotte JM, Graham R, Kahler L, Young L, Goodnough S. Epidemiology of nosocomial infection and resistant organisms in patients admitted for the first time to an acute rehabilitation unit. Clin Infect Dis. 2000;30(3):425-32. 37. Azim A, Dwivedi M, Rao PB, Baronia AK, Singh RK, Prasad KN, et al. Epidemiology of bacterial colonization at intensive care unit admission with emphasis on extended-spectrum beta-lactamase- and metallo-beta-lactamase-producing Gram-negative bacteria--an Indian experience. J Med Microbiol. 2010;59(Pt 8):955-60. 38. Falagas M, Rafailidis P. Attributable mortality of Acinetobacter baumannii: no longer a controversial issue. Crit Care. 2007;11(3):134. 39. Falagas M, Kasiakou S, Rafailidis P, Zouglakis G, Morfou P. Comparison of mortality of patients with Acinetobacter baumannii bacteraemia receiving appropriate and inappropriate empirical therapy. J Antimicrob Chemother. 2006;57(6):1251-4. 40. Vahdani P, Yaghoubi T, Aminzadeh Z. Hospital Acquired Antibiotic-Resistant Acinetobacter Baumannii Infections in a 400-Bed Hospital in Tehran, Iran. Int J Prev Med. 2011;2(3):127-30. 41. Mohanty S, Maurya V, Gaind R, Deb M. Phenotypic characterization and colistin susceptibilities of carbapenem-resistant of Pseudomonas aeruginosa and Acinetobacter spp. J Infect Dev Ctries. 2013;7(11):880-7. 42- Behzadnia S, Davoudi A, Rezai MS, Ahangarkani F. Nosocomial Infections in Pediatric Population and Antibiotic Resistance of the Causative Organisms in North of Iran. Iranian Red Crescent Medical Journal 2014;16(2):e14562. doi:10.5812/ircmj.14
Add your comments about this article
Your username or Email:

CAPTCHA


XML     Print


Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:

Babamahmoodi F, Ahangarkani F, Davoudi A. Hospital-Acquired Infections, Bacterial Causative Agents And Antibiotic Resistance Pattern In Intensive Care Units At Teaching Hospitals In North Of Iran. Int J Med Invest 2015; 4 (1) :152-160
URL: http://intjmi.com/article-1-94-en.html


Rights and permissions
Creative Commons License This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
Volume 4, Issue 1 (march 2015) Back to browse issues page
International Journal of Medical Investigation
Persian site map - English site map - Created in 0.05 seconds with 37 queries by YEKTAWEB 4645